हिन्दी
English
मराठी
বাংলা
தமிழ்
മലയാളം
ગુજરાતી
తెలుగు
ಕನ್ನಡ
ଓଡ଼ିଶା
Business
Tech
World
Health
NEWS
VIDEOS
PHOTOS
Web Stories
LIVE TV
GO
Latest
Assembly Election
India
Ahmedabad
Bengaluru
Chennai
Hyderabad
Kolkata
Mumbai
Pune
Cricket
Success Story
Entertainment
Hollywood
Music
Bollywood
Television
Regional
Movie Review
Lifestyle
Relationship
Travel
Food & Recipes
Fashion
Culture
Spirituality
Business
Economy
Markets
Companies
Real Estate
International Business
Personal Finance
Automobile
Technology
Gadgets
Gaming
Internet & Social Media
Apps
Mobiles
World
Asia
Africa
Americas
Australia-Oceania
Europe
Auto
Mobility
Viral
Diabytes
Fables of Facades
Archived Videos
Newsletter
Fables of Facades
Latest
Assembly Election
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Latest
Assembly Election
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Advertisement
X
News
Moderna
Moderna News
COVID-19
26 Aug 2022
Moderna sues Pfizer, BioNTech for Covid-19 vaccine patent infringement
Moderna CEO Stephane Bancel said in a prepared statement that the vaccine developer pioneered that technology and invested billions of dollars in creating it.
COVID-19
09 Apr 2022
Moderna recalls thousands of Covid-19 vaccine doses in Europe, here's why
Over 900 million doses of the Moderna COVID-19 vaccine have been administered worldwide to date. Moderna said on Friday it did not believe the contamination posed a risk to other vials in the lot.
Moderna
18 Mar 2022
Moderna seeks FDA approval for fourth Covid vaccine to be used as booster shot
Moderna is now seeking Food and Drug Administration (FDA) approval for its fourth shot of the Covid-19 vaccine to be administered as a booster dose in eligible adults.
Omicron
21 Dec 2021
Moderna says its booster shot effective against Omicron
The 100 microgram Moderna booster shot increases neutralising titers 83-fold higher than pre-boost levels The results have not been peer reviewed
Moderna
20 Dec 2021
Moderna booster effective against Omicron, claims drugmaker
An authorised dose of 50 microgram booster increased neutralising antibody levels against Omicron by approximately 37-fold compared to pre-boost levels, the company said in a statement.
COVID-19
21 Oct 2021
US approves new booster of COVID-19 vaccines, mix and match dose
FDA approved the use of third doses of Moderna and Johnson & Johnson vaccines. FDA also approved "mix and match" booster doses.
COVID 19
01 Sep 2021
Contracting Covid 19 earlier doesn't mean you have a better immunity now
Antibody response decreases after two months of first dose Second dose may protect against the new variants
COVID 19
23 Aug 2021
US gives full approval to Pfizer's COVID-19 vaccine
More than 200 million Pfizer vaccine used in the US It will be used for people above 16 years of age
Moderna
10 Aug 2021
Moderna vaccine approved in Australia amid lockdown in most populous state
Australia witnessing rising number of coronavirus cases Two doses of Moderna vaccine will be required
Bharat biotech
13 Jul 2021
Document for emergency use listing of Covaxin submitted to WHO: Bharat Biotech
WHO has approved vaccines Pfizer-BioNTech, AstraZeneca- SK Bio/SII, Johnson & Johnson Janssen, Moderna, and Sinopharm for emergency use The trial was conducted on 25,800 subjects, and the data submitted to the Subject Expert Committee (SEC) showed the vaccine was “well-tolerated”
COVID-19
10 Jul 2021
Pfizer, Moderna in discussions with India: NITI Aayog's VK Paul
Moderna and Pfizer had sought indemnity which would ensure that they can’t be booked in case of any adverse effect of the vaccine. Earlier, in June, Moderna had announced that India has granted permission for its COVID-19 vaccine to be imported into the country for restricted use in an emergency situation. Pfizer has not even applied for an emergency use authorisation in the country.
COVID-19 vaccine
08 Jul 2021
India expects to receive 3-4 million doses of Pfizer, Moderna vaccine by Aug
The country has so far administered 358.1 million vaccine doses giving at least one dose to 31% of its estimated adult population of 944 million. Many experts believe that the country needs to administer at least 10 million doses a day to achieve its aim of immunising all adults by December. India mainly relies on a licensed version of the AstraZeneca vaccine.
coronavirus vaccine
03 Jul 2021
As India gears up for Moderna, list of other vaccine options available
Moderna will become the fourth vaccine to be available for use in India The Centre plans to provide the Moderna doses directly to states Pfizer will supply one billion doses to India within this year
COVID-19
29 Jun 2021
After Moderna, Pfizer, Johnson & Johnson COVID-19 vaccines likely to get nod
Cipla got DCGI approval for emergency use of Moderna vaccine Pfizer and Johnson & Johnson could also get nod soon J&J aims to make single-dose vaccine available in India
Moderna
29 Jun 2021
Vaccine no. 4 is almost here, Cipla gets nod to import Moderna jab
Cipla on Monday sought the DCGI’s nod for importing the Moderna’s vaccine and submitted an application
COVID-19
18 Jun 2021
Get Pfizer or Moderna for second jab after receiving AstraZeneca vaccine: NACI
There are two mRNA vaccines currently approved for use in Canada produced by Pfizer-BioNTech and Moderna NACI said the mixed-dose schedule provides better protection against the disease
COVID-19
08 Jun 2021
Can Menstruating women get COVID jab? Myths related to vaccination BUSTED!
There are no harmful effects of vaccination recorded in lactating or breastfeeding mothers It’s best to get vaccinated and then approach pregnancy so that your pregnancy is safer and healthier
Pfizer
02 Jun 2021
Centre may grant indemnity to Pfizer and Moderna: Sources
Centre may grant indemnity to COVID vaccine manufacturers Pfizer and Moderna Sources said Centre may grant a concessional request of legal protection from any claims linked to the use of their Covid-19 vaccines in India
COVID-19
02 Jun 2021
Next-gen COVID shots: Cheaper, effective against more viruses
The pharma companies aim to develop shots that will be more effective against certain variants of the SARS-CoV-2 virus, that causes COVID-19 Most companies investing in COVID-19 vaccines are banking on the idea that regular boosters will be necessary
COVID-19
01 Jun 2021
B1617 variant spreading worldwide at 'frightening speed': Experts
B1617 has mutated to spread more easily from person to person, and may dampen the protection conferred by vaccines as well as natural infection Various researches have shown that the Pfizer, Moderna and AstraZeneca vaccines are effective against B1617
1116216
1
2
Loading...
Trending news
DNA Video
DNA: Eknath Shinde Steps Back, BJP to Decide CM
DNA Video
DNA: Where Is Bushra Bibi Amidst Pakistan’s Chaos?
DNA Video
DNA: Chhattisgarh Couple Promotes Helmet Safety at Wedding, Video Goes Viral
DNA Video
DNA: IIT Kanpur Develops ‘Invisible’ Shield for Indian Army!
DNA Video
DNA: AIMPLB's 'provocative plan' on Waqf leaked!
DNA Video
DNA: Sambhal riots- shocking revelations in police FIR
DNA Video
DNA: Violence Erupts in Bangladesh After ISKCON Monk Chinmoy Das’ Arrest
DNA Video
DNA: Anmol Bishnoi Seeks Asylum in the U.S.
DNA Video
DNA: Adani Case - Corruption Allegations Rock Indian Markets
DNA Video
DNA: Were Muslims Stopped from Voting in UP By-Elections?
Subscribe Now
×
Enroll for our free updates
Please enter full name.
Please enter valid email address.
https://zeenews.india.com/
Subscribe Now
Thank you
×
Cookies Settings
Reject
Accept Cookies
NEWS ON ONE CLICK